(a) Reporting entities described in §97.132 of this title (relating to Who Shall Report Sexually Transmitted Diseases) shall report all information required by the department for each person (which includes an HIV-exposed infant) who has or is suspected of having an STD, as well as for any specimen derived from a human body that yields microscopic, cultural, serological or any other evidence of a suspected STD.
(b) The department has established the reporting procedures required under Texas Health and Safety Code, §81.044, including the designation of specific forms and methods of reporting. The required written reports, electronic reports, and telephone reports shall be made in a complete, accurate and timely manner, all in accordance with §97.134 of this title (relating to How to Report Sexually Transmitted Diseases).
(c) All persons required to report under §97.132 of this title, must report the following (each report must either use the department's form specified in this subsection, or a substitute form which captures all the data elements of the specified department form):
  (1) All adult or adolescent (13 years of age or older) HIV infections and AIDS (stage 3 of HIV infection) diagnoses for individuals 13 years of age or older (see the most current version of the department's Texas HIV/AIDS Adult/Adolescent case report form (available as specified in §97.134 of this title.
  (2) All pediatric (less than 13 years of age) HIV infections and AIDS (stage 3 of HIV infection) diagnoses (see the most current version of the department's Texas HIV/AIDS pediatric case report form (available as specified in §97.134 of this title)).
  (3) All HIV-positive pregnant women. (see the most current version of the department's Texas HIV/AIDS Adult/Adolescent case report form (available as specified in §97.134 of this title)).
  (4) All HIV-exposed infants (see the most current version of the department's Texas HIV/AIDS Pediatric case report form (available as specified in §97.134 of this title)).
  (5) All chancroid, Chlamydia trachomatis, Neisseria gonorrhea, and syphilis infections (see the most current version of the department's Confidential Report of Sexually Transmitted Diseases form (STD-27) (available as specified in §97.134 of this title)).
  (6) All congenital syphilis infections (see the most current version of the CDC's Congenital Syphilis Case Investigation and Report form (available as specified in §97.134 of this title)).
  (7) All positive or reactive results from point of care testing for STDs (see the most current version of the department's Confidential Report of Sexually Transmitted Diseases form (STD-27) (available as specified in §97.134 of this title)).
(d) Persons described in §97.132(a)(2) of this title must report the following regarding any specimen derived from a human body that yields microscopic, cultural, serological or any other evidence of a suspected STD (each report must either use the department's form specified in this subsection, or a substitute form which captures all the data elements of the specified department form):
  (1) All positive or reactive STD test results, including screening tests; all HIV viral loads (detectable and non-detectable); and all CD4+T-lymphocyte cell counts and percentages (see the most current version of the department's Notification of Laboratory Test Findings Indicating Presence of Chlamydia trachomatis, Gonorrhea, Syphilis, Chancroid, HIV Infections or CD4 Counts form (STD-28) (available as specified in §97.134 of this title)).
  (2) HIV DNA or RNA virologic tests on all infants suspected of HIV exposure from birth to three years of age, regardless of the test findings (e.g., negative or positive) (see the most current version of the department's STD-28 form (available as specified in §97.134 of this title)).
  (3) All supplemental tests for syphilis and HIV that result from an initial positive screening test, regardless of result (e.g., reactive or non-reactive) (see the most current version of the department's STD-28 form (available as specified in §97.134 of this title)).
  (4) All HIV nucleotide sequences that are resultant of genotypic testing, including HIV drug resistance testing (see the most current version of the department's STD-28 form (available as specified in §97.134 of this title)).

Source Note: The provisions of this §97.133 adopted to be effective January 1, 1999, 23 TexReg 12669; amended to be effective March 20, 2003, 28 TexReg 2335; amended to be effective January 1, 2010, 34 TexReg 9445; amended to be effective October 14, 2015, 40 TexReg 7234